Level D· Scientific groundwork from lab and animal studiesLaboratory StudyPubMed

Integrative transcriptomic and proteomic profiling reveals altered thymocyte development and microenvironment remodeling during natural thymic atrophy.

Lin W., Sun F., Pan H., Yao J., Wang M., Ye K.

Laboratory Study on Chronic Inflammation, published in Front Cell Dev Biol (2026) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Laboratory Study
Journal
Front Cell Dev Biol (2026)
Country
Switzerland
Reported sample size
—
Source database
PubMed
PMID
42428792
DOI
10.3389/fcell.2026.1816627

Abstract (original English)

Age-related thymic atrophy (ARTA) is a hallmark of immunosenescence, yet the earliest thymocyte developmental checkpoints affected by increasing age and the coordinated molecular programs that drive thymic degeneration remain incompletely defined. We compared young (1-month-old) and middle-aged (MA, 12-month-old) male ICR mice using thymus weight/index measurement, histopathology, peripheral blood cell analysis, and immunostaining of thymic markers. We further performed RNA-seq and data-dependent acquisition (DDA) proteomics, followed by integrated transcriptomic-proteomic pathway analyses. Finally, we analyzed public human thymus datasets to assess the translational relevance of our findings. Middle-aged mice exhibited marked thymic involution with reduced thymus weight and thymic index, accompanied by peripheral lymphopenia and reduced peripheral T-cell counts, while myeloid populations (neutrophils and monocytes) increased. Pathological examination revealed lipid droplet accumulation in the thymus of aged mice, along with decreased Ki-67 expression and an increased number of apoptotic cells. Histologically, aged thymuses showed cortical thinning and an indistinct corticomedullary boundary. Reduced cortical CD25 with increased CD44 is suggestive of a possible developmental impediment around the DN1-to-DN2 transition; in parallel, CD3 + , CD4 + , and CD8 + T cells were reduced

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research